Pfizer Manufacturing Deutschland GmbH (Packaging (primary and secondary), labeling, quality control, batch release)
UkraineAll drugs from this manufacturer
-
The drug is indicated for the treatment of schizophrenia in adults, as well as for the treatment of moderate manic or mixed episodes in patients with bipolar I disorder.
Dosage form: capsules, hard
Active substance Dosage ziprasidone 40 mg ATC: N05AE04
-
The drug is indicated for the treatment of schizophrenia in adults, as well as for the treatment of moderate manic or mixed episodes in patients with bipolar I disorder.
Dosage form: capsules, hard
Active substance Dosage ziprasidone 80 mg ATC: N05AE04
-
The drug is indicated for the treatment of schizophrenia in adults, as well as moderate manic or mixed episodes in patients with bipolar I disorder.
Dosage form: capsules, hard
Active substance Dosage ziprasidone 20 mg ATC: N05AE04